Literature DB >> 16870757

Genetic and biochemical characterization of FUS-1 (OXA-85), a narrow-spectrum class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum.

Christine Voha1, Jean-Denis Docquier, Gian Maria Rossolini, Thierry Fosse.   

Abstract

Previous studies have reported beta-lactamase-mediated penicillin resistance in Fusobacterium nucleatum, but no beta-lactamase gene has yet been identified in this species. An F. nucleatum subsp. polymorphum strain resistant to penicillin and amoxicillin was isolated from a human periodontitis sample. DNA cloning and sequencing revealed a 765-bp open reading frame encoding a new class D beta-lactamase named FUS-1 (OXA-85). A recombinant Escherichia coli strain carrying the bla(FUS-1) gene exhibited resistance to amoxicillin with a moderate decrease in the MICs with clavulanic acid. The bla(FUS-1) gene was found in two additional clonally unrelated F. nucleatum subsp. polymorphum isolates. It was located on the chromosome in a peculiar genetic environment where a gene encoding a putative transposase-like protein is found, suggesting a possible acquisition of this class D beta-lactamase gene. The FUS-1 enzyme showed the closest ancestral relationship with OXA-63 from Brachyspira pilosicoli (53% identity) and with putative chromosomal beta-lactamases of Campylobacter spp. (40 to 42% identity). FUS-1 presents all of the conserved structural motifs of class D beta-lactamases. Kinetic analysis revealed that FUS-1 exhibits a narrow substrate profile, efficiently hydrolyzing benzylpenicillin and oxacillin. FUS-1 was poorly inactivated by clavulanate and NaCl. FUS-1 is the first example of a class D beta-lactamase produced by a gram-negative, anaerobic, rod-shaped bacterium to be characterized.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870757      PMCID: PMC1538689          DOI: 10.1128/AAC.00058-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.

Authors:  E Könönen; A Kanervo; K Salminen; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636.

Authors:  B A Rasmussen; Y Gluzman; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Fusobacterium nucleatum subsp. fusiforme subsp. nov. and Fusobacterium nucleatum subsp. animalis subsp. nov. as additional subspecies within Fusobacterium nucleatum.

Authors:  S E Gharbia; H N Shah
Journal:  Int J Syst Bacteriol       Date:  1992-04

Review 4.  Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections.

Authors:  S M Finegold; H M Wexler
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 5.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Substrate-induced inactivation of the OXA2 beta-lactamase.

Authors:  P Ledent; J M Frère
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

7.  Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A beta-lactamases.

Authors:  M B Rogers; A C Parker; C J Smith
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

8.  Molecular and genetic analysis of the Bacteroides uniformis cephalosporinase gene, cblA, encoding the species-specific beta-lactamase.

Authors:  C J Smith; T K Bennett; A C Parker
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

Review 9.  Fatal sepsis due to a beta-lactamase-producing strain of Fusobacterium nucleatum subspecies polymorphum.

Authors:  E J Goldstein; P H Summanen; D M Citron; M H Rosove; S M Finegold
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

10.  Genetic and biochemical analysis of a novel Ambler class A beta-lactamase responsible for cefoxitin resistance in Bacteroides species.

Authors:  A C Parker; C J Smith
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more
  10 in total

1.  The Soil Microbiota Harbors a Diversity of Carbapenem-Hydrolyzing β-Lactamases of Potential Clinical Relevance.

Authors:  Dereje Dadi Gudeta; Valeria Bortolaia; Greg Amos; Elizabeth M H Wellington; Kristian K Brandt; Laurent Poirel; Jesper Boye Nielsen; Henrik Westh; Luca Guardabassi
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

2.  Preparation and physicochemical characterization of amoxicillin beta-cyclodextrin complexes.

Authors:  Catherine Bisson-Boutelliez; Stephane Fontanay; Chantal Finance; Francine Kedzierewicz
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

Review 3.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

4.  Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.

Authors:  Filomena De Luca; Chantal Giraud-Morin; Gian Maria Rossolini; Jean-Denis Docquier; Thierry Fosse
Journal:  Antimicrob Agents Chemother       Date:  2010-02-01       Impact factor: 5.191

5.  Phenotypic Adaptation to Antiseptics and Effects on Biofilm Formation Capacity and Antibiotic Resistance in Clinical Isolates of Early Colonizers in Dental Plaque.

Authors:  David L Auer; Xiaojun Mao; Annette Carola Anderson; Denise Muehler; Annette Wittmer; Christiane von Ohle; Diana Wolff; Cornelia Frese; Karl-Anton Hiller; Tim Maisch; Wolfgang Buchalla; Elmar Hellwig; Ali Al-Ahmad; Fabian Cieplik
Journal:  Antibiotics (Basel)       Date:  2022-05-19

6.  Identification of Therapeutic Targets in an Emerging Gastrointestinal Pathogen Campylobacter ureolyticus and Possible Intervention through Natural Products.

Authors:  Kanwal Khan; Zarrin Basharat; Khurshid Jalal; Mutaib M Mashraqi; Ahmad Alzamami; Saleh Alshamrani; Reaz Uddin
Journal:  Antibiotics (Basel)       Date:  2022-05-18

7.  Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.

Authors:  Djalal Meziane-Cherif; Thierry Lambert; Marine Dupêchez; Patrice Courvalin; Marc Galimand
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

Review 8.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

9.  Telling the whole story in a 10,000-genome world.

Authors:  Robert G Beiko
Journal:  Biol Direct       Date:  2011-06-30       Impact factor: 4.540

Review 10.  Acquired Class D β-Lactamases.

Authors:  Nuno T Antunes; Jed F Fisher
Journal:  Antibiotics (Basel)       Date:  2014-08-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.